Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

J&J’s Marketing of Risperdal Violated Law, Arkansas Jury Rules
Bloomberg
Wednesday, April 11, 2012 - 9:31am
tags:
Arkansas, JNJ, Risperdal
J&J looks for workaround to ease Doxil shortage
Fierce Pharma
Tuesday, April 10, 2012 - 11:36am
tags:
Doxil, drug shortages, JNJ
Teva May Raise Forecast After Provigil Decision, Analyst Says
Bloomberg
Tuesday, April 10, 2012 - 11:21am
tags:
Teva Pharmaceuticals, Provigil
Breaking The Mold Of Oncology Drug Development
Seeking Alpha
Tuesday, April 10, 2012 - 11:20am
tags:
Amgen, Dendreon, Micromet, ImmunoCellular
2 Biotech Stocks To Consider Now, 1 To Avoid
Seeking Alpha
Tuesday, April 10, 2012 - 11:19am
tags:
Spectrum Pharmaceuticals, Savient, Dendreon, Keryx
ViroPharma Stock Tumbles As Vancocin Goes Generic
Investors.com
Tuesday, April 10, 2012 - 11:18am
tags:
Vancocin, generics, ViroPharma, Watson Pharmaceuticals, antibiotics
Dendreon: Healthy Competition Will Boost Profits
Seeking Alpha
Tuesday, April 10, 2012 - 11:15am
tags:
Dendreon, Provenge, prostate cancer, Abbott Laboratories, Bristol-Myers Squibb, JNJ, Sanofi
Vivus Tumbles On Extended FDA Review
Barron's
Tuesday, April 10, 2012 - 11:08am
tags:
FDA, Vivus, Qnexa, obesity
Amgen to buy KAI Pharma
Marketwatch
Tuesday, April 10, 2012 - 9:32am
tags:
KAI Pharmaceuticals, Amgen, M&A
Closing arguments set in Arkansas trial over J&J subsidiary's antipsychotic drug Risperdal
Yahoo/AP
Tuesday, April 10, 2012 - 9:31am
tags:
JNJ, Risperdal, Arkansas, Janssen
Vaccines group gets cut-price GSK, Merck rotavirus shots
Reuters
Tuesday, April 10, 2012 - 9:29am
tags:
GAVI, Merck, GSK, vaccines, rotavirus
Don't Expect much Growth from Pfizer this Year
Motley Fool
Tuesday, April 10, 2012 - 9:28am
tags:
Pfizer
4 Pharmaceuticals That Could Plummet This Year
Seeking Alpha
Tuesday, April 10, 2012 - 9:26am
tags:
Pfizer, Abbott Laboratories, JNJ, Angiotech
SciClone Pharmaceuticals Is Dramatically Increasing Profits
Seeking Alpha
Monday, April 9, 2012 - 5:46pm
tags:
SciClone
FDA will take 3 more months to review Vivus drug
Yahoo/AP
Monday, April 9, 2012 - 5:43pm
tags:
Vivus, FDA, Qnexa, obesity
Will Human Genome End Up Blazing A Trail For Others?
Seeking Alpha
Monday, April 9, 2012 - 5:43pm
tags:
Human Genome Sciences, GSK, Eli Lilly, Benlysta, Anthera, Immunomedics, lupus
Provenge And The Immunodepletion Theory: The Facts
Seeking Alpha
Monday, April 9, 2012 - 1:08pm
tags:
Provenge, Dendreon, immunodepletion, prostate cancer
Johnson & Johnson: Valuing The Dividends
Seeking Alpha
Monday, April 9, 2012 - 1:03pm
tags:
dividends, JNJ
Optimer fires chairman, CFO; shares fall
Yahoo/Reuters
Monday, April 9, 2012 - 12:23pm
tags:
Optimer
Icahn says sues Amylin, urges sale
Reuters
Monday, April 9, 2012 - 12:22pm
tags:
Amylin, Carl Icahn

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.